Vienna, Austria

Charlotte Brey


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Charlotte Brey: Innovator in Protein-Protein Interaction Systems

Introduction

Charlotte Brey is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of protein-protein interaction systems, holding a total of 2 patents. Her innovative work focuses on the development of ligand regulated systems that enhance the understanding of molecular interactions.

Latest Patents

One of her latest patents is a ligand regulated protein-protein interaction system based on a lipocalin-fold molecule. This system includes a lipocalin-fold molecule, a lipocalin-fold ligand with a low molecular weight of 1500 Da or below, and a lipocalin-fold binding interaction partner. The unique aspect of this invention is that the lipocalin-fold molecule can bind to the ligand, resulting in a binding affinity that is at least 10-fold higher than when the molecule is not bound to the ligand. Furthermore, the binding interaction partner is not a naturally occurring protein with an affinity of <10 μM to any naturally occurring lipocalin-fold molecule in the presence of any lipocalin-fold ligand.

Career Highlights

Charlotte has worked with esteemed organizations such as St. Anna Kinderkrebsforschung and Universität für Bodenkultur Wien. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific advancements.

Collaborations

Throughout her career, Charlotte has collaborated with notable colleagues, including Michael Traxlmayr and Christian Obinger. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.

Conclusion

Charlotte Brey is a pioneering inventor whose work in protein-protein interaction systems has the potential to impact various scientific fields. Her patents reflect her dedication to advancing molecular biology and understanding complex interactions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…